US FDA granted Humanitarian Use Device for Xeltis pulmonary valve

2016-03-23T16:00:23+01:00March 23rd, 2016|News|

The US FDA granted Humanitarian Use Device (HUD) designation for Xeltis’ first bioabsorbable cardiac pulmonary valve, for the correction or reconstruction of right ventricular outflow tract (RVOT). HUD designation is granted to medical devices that may help people with rare [...]

Xeltis pulmonary conduit data presented at HVS

2016-03-17T16:00:46+01:00March 17th, 2016|News|

Results from Xeltis' first feasibility clinical trial have been presented at the annual Heart Valve Society Scientific Meeting in New York City on 17 March by leading investigator and world-renowned cardiac surgeon, Professor Leo Bockeria. The results of the study [...]

Xeltis to present to leading investors at European forum

2016-03-15T09:00:07+01:00March 15th, 2016|News|

Laurent Grandidier, Xeltis CEO, will present at this year’s European Life Science CEO Forum and Exhibition, taking place on 15-16 March in Zurich. The meeting is a highly transactional forum designed for both venture-funded and small-cap companies to engage with [...]

Xeltis CEO to present at leading BioCapital event

2016-03-03T09:18:54+01:00March 3rd, 2016|News|

On 9 March, Xeltis CEO Laurent Grandidier will be presenting at BioCapital Europe Conference, Europe’s premier life sciences investment conference, offering VCs and institutional investors unique and timely access to around 40 exciting European biotech companies. Organized by LSP (Life [...]

Heart Awareness Month

2016-02-24T15:30:28+01:00February 24th, 2016|News|

February marks Heart Awareness Month for many countries and Xeltis is committed to supporting organizations that run awareness campaigns about cardiovascular health.  Please visit our social media channels to flag or view some of the best campaigns in 2016. While [...]

Supporting CHD Awareness Week 2016

2016-02-11T09:34:36+01:00February 11th, 2016|News|

Xeltis is marking Congenital Heart Disease (CHD) awareness week, 7-14 February, by actively supporting those organizations running associated awareness campaigns. For all those who get in touch, we will share your work across our network. If you are a non-for-profit organization working [...]

Xeltis appoints new CFO

2016-02-02T09:00:32+01:00February 2nd, 2016|News|

Xeltis has bolstered its executive team with the appointment of Paul van Hagen as Chief Financial Officer. Van Hagen joins Xeltis with over 20 years of experience as a financial professional, working for private and public healthcare companies. In his [...]

Dutch figurehead Professor Jan Raaijmakers visits Xeltis

2016-01-29T17:33:04+01:00January 29th, 2016|News|

Professor Jan Raaijmakers, the Dutch figurehead for the top sector ‘Life Sciences and Health’, visited Xeltis’ facilities during a tour of the Eindhoven University of Technology. Xeltis was one of three healthcare university spin-offs included in Professor Raaijmakers’ trip focusing [...]

How Xeltis overcame medtech financial challenges

2016-01-22T23:46:53+01:00January 22nd, 2016|News|

Xeltis CEO, Laurent Grandidier, discusses how the company secured significant Series B funding in spite of the increasingly tough medtech financial environment in European CEO magazine. “A truly innovative and scalable technology that may substantially benefit the healthcare system, the [...]

Go to Top